Cite
MLA Citation
J Zhang et al.. “Biomarker assessment of the CBCSG006 trial: a randomized phase III trial of cisplatin plus gemcitabine compared with paclitaxel plus gemcitabine as first-line therapy for patients with metastatic triple-negative breast cancer.” Annals of oncology, vol. 29, 2018, pp. 1741–1747. http://access.bl.uk/ark:/81055/vdc_100095501409.0x00003a